Gomez-Ganda L, Parramon-Teixido CJ, Giralt-Garcia G, Fernandez-Garcia C, Ferrer-Menduina Q, Cabanas-Poy MJ.
Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age
Front Pharmacol. 2025 Feb 18;16:1502375.
DOI: 10.3389/fphar.2025.1502375
IF: 4.4
RESEARCH GROUPS
Basic, Translational and Clinical Pharmacy Research
33
Number of publications
42.42
%
% Q1
21.21
%
% D1
75.76
%
% Leadership
64.00
%
% Female Leadership
1.02
CROWN (2021-2025)
7.30
%
HCP10% (2021-2025)
84.85
%
% Open access
0.00
%
% International Collaboration
2
Highly cited papers / HCP 1% (2021-2025)
0
Publications in high-IF journals with high Altmetric scores
2
Number of Ongoing Projectes (total)
0
International ongoing projects
1
Number of New projects (total)
0
International new projects
1
Number of Active clinical Trials
0
Number of New Clinical Trials
2
Number of Theses
The “Basic, Translational and Clinical Pharmacy Research” group is committed to advancing personalized medicine, with a focus on drug stability in individualized preparations for oral and parenteral administration, population pharmacokinetic/pharmacodynamic models, and pharmacogenomics. We also conduct advanced research, including drug evaluation, effectiveness and safety studies, as well as mobile health and telepharmacy. Our team excels in interdisciplinary research, actively engaging in joint projects with other groups. In 2025, our group consisted of 40 members and produced 48 publications in indexed journals 17 Q1 and 6 Q2, we published 2 theses and worked on 12 different own projects, 7 of which received grant funding. Our research has contributed to the study of biological medications and pharmacokinetic models for various drugs and pathologies. We also continued explored the innovative project 3D printing for personalized pediatric treatments.
CORE/MISSIONS
- Aging
- AI, Data, Imaging & Digital Health
- Innovative & Advanced Therapies
- Rare Diseases
- Transplant & Immunomodulation
PROGRAMS
- Woman, Gender & Diversity Perspective in Health Research
TEAM
Group Leader
Maria Queralt Gorgas Torner
Principal Investigator (PI)
Maria Queralt Gorgas Torner, Bruno Montoro Ronsano, David Berlana Martin
Researchers
Carla Alonso Martínez, Ángel G. Arévalo Bernabé, Maria Josep Cabañas Poy, David Campany Herrero, Ignacio Cardona Pascual, Maria Josep Carreras Soler, Salvador Clemente Bassa, Susana Clemente Bautista, Laura Doménech Moral, Beatriz Magdalena García Palop, Maria Rosa Gómez Domingo, Laura Gómez Ganda, Maria Guerra Gonzalez, Juan Carlos Juárez Giménez, María Eugenia Palacio Lacambra, Alba Pau Parra, Berta Renedo Miró, Pablo Sánchez Sancho, Emili Vallvé Alcón, Guillem Vancells Lujan, Jana Vidal Otero, Carme García Esquerda, Jaime Llata Ortega, Cristina Raventós Aymar, Helena Genestal Vicente, Àfrica Hontalba Rifà, Andrea Pérez Manrique, Arnau Mariscal Puig, Maria Carmen Torres Moreno, Pilar Suñé Martín, David Conde Estevez, Margarita Garau Gomila, David Berlana Martín, J. Bruno Montoro Ronsano
PhD Students
Sonia García García, María Larrosa García, Patricia Marrero Álvarez, Carlos Javier Parramón Teixidó
SELECTED PUBLICATIONS
Parramon-Teixido CJ, Rodriguez-Pombo L, Basit AW, Worsley A, Canete-Ramirez C, Alvarez-Lorenzo C, Cabanas-Poy MJ, Goyanes A.
A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care.
Drug Deliv Transl Res. 2025 Sep;15(9):3078-3097.
DOI: 10.1007/s13346-025-01868-y.
IF: 5.7
Domenech-Moral L, Garcia-Garcia S, Pau-Parra A, Sosa M, Puertas Sanjuan A, Bonilla C, Gallart E, Castellote L, Faixo P, Guevara J, Vilanova A, Martinez-Pla M, Conto A, Nuvials X, Lalueza P, Ferrer R, Gorgas MQ, Riera J
Pharmacokinetics of Isavuconazole During Extracorporeal Membrane Oxygenation Support in Critically Ill Patients: A Case Series.
Antibiotics (Basel). 2025 Jun 12;14(6):600
DOI: 10.3390/antibiotics14060600
IF: 4.3
Varela-Gonzalez-Alle, Sanchez-Salinas MA, Troconiz I, Iacoboni G, Alonso-Martinez C, Carreras-Soler MJ, Carpio C, Farriols-Danes A, Guerra-Gonzalez M, Rivas-Delgado A, Rivera Sanchez L, Feijoo S, Valdivia C, Barba P, Miarons M.
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.
Pharmaceutics. 2025 Dec 10;17(12):1592.
DOI: 10.3390/pharmaceutics17121592.
IF: 4.9
Pau-Parra A, Luque S, Domenech L, Martinez-Pla M, Nuvials X, Garay MS, Los-Arcos I, Conto A, Lasteros F, Gallart E, Torner MQG, Ferrer R, Riera J.
Aztreonam-avibactam pharmacokinetics during extracorporeal membrane oxygenation support: first insights from a case report
Pharmaceuticals (Basel). 2025 Dec 21;19(1):16.
DOI: 10.3390/ph19010016.
IF: 4.6
SELECTED PROJECTS
Screening and Linkage to Hepatitis C Care in Patients Attended at the Outpatient Unit of the Pharmacy Service in a Tertiary Hospital in Spain
Principal Investigator: Jana Vidal Otero
Agency: AbbVie Spain, S.L.U.
Funding: 15,000 €
Period: 2023-2025
Aplicación clínica de la impresión 3D para el tratamiento personalizado en pediatría
Principal Investigator: M. José Cabañas Poy
Agency: Sociedad española Farmacia Hospitalaria
Funding: 14,700€
Period: 2022-2025
Optimización del tratamiento quimiolinfodeplectivo con fludarabina previo a la infusión de terapia de células T con receptor de antígeno quimérico (CAR-T)
Principal Investigator: Pere Barba Suñol
Agency: Proyecto PI21/00197, Instituto de Salud Carlos III
Funding: 111,320 €
Period: 2022-2025
Conocimiento de la posología óptima de meropenem en pacientes críticos con oxigenación por membrana extracorpórea mediante farmacocinética
Principal Investigator: Alab Pau Parra
Agency: Colegio Oficial de Farmacéuticos de Barcelona
Funding: 7,000 €
Period: 2025-26
Farmacovigilancia de terapia génica in vivo en España: Onasemnogén abeparvovec y Voretigén neparvovec
Principal Investigator: Octavio Balle
Agency: Sociedad Española Farmacia Hospitalaria
Funding: 11,500 €
Period: 2024-2025
PATENTS
DISSEMINATION ACTIVITIES
Training Course in Paediatric Pharmacy
Place: Vall Hebron University Hospital
Date: March 24-28, 2025
Brief: Various researchers provide continuing education in the field of pediatrics
Introductory course on the pharmacotherapy of blood products
Place: Vall d'Hebron University Hospital and virtual
Date: November 2025
Brief: Training on new developments in blood products
Course on Medicines and Kidney Disease
Place: Virtual
Date: March 21–July 25, 2025
Brief: Continuing education in kidney disease and drugs
Course on Pharmacogenetics and Pharmacogenomics: Personalised Precision Medicine
Place: Virtual
Date: May-August 2025
Brief: Continuing education in personalized precision medicine
Oncology Pharmacy Specialty Certification
Place: Sociedad Española Farmacia Hospitalaria
Date: 2025
Brief: Board of Pharmaceutical Specialties on oncology pharmacy
